Search research articles
Contact Us
Filters
Showing results (371-380 of 792) with videos related to
Page
of 80
Sort By:
The Journal of Infectious Diseases
|
November 1, 1995
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 Team
R H Haubrich, C Flexner, M M Lederman, et al.
The New England Journal of Medicine
|
August 27, 1992
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group
J O Kahn, S W Lagakos, D D Richman, et al.
Antiviral Therapy
|
February 6, 2004
Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance
Joel E Gallant, Peter Z Gerondelis, Mark A Wainberg, et al.
The Journal of Biological Chemistry
|
August 5, 1993
Amino acid substitutions in HIV-1 reverse transcriptase with corresponding residues from HIV-2. Effect on kinetic constants and inhibition by non-nucleoside analogs
A Bacolla, C K Shih, J M Rose, et al.
Medical Care
|
August 11, 1991
A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection
A W Wu, H R Rubin, W C Mathews, et al.
Nature
|
September 6, 1990
Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies
J M Zarling, P A Moran, O Haffar, et al.
Journal of Clinical Microbiology
|
August 1, 1987
Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection
R S Smith, R B Naso, J Rosen, et al.
Plos Pathogens
|
November 30, 2016
Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model
Cory H White, Bastiaan Moesker, Nadejda Beliakova-Bethell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials
J F Seligmann, D Fisher, C G Smith, et al.
JAMA
|
September 7, 1984
Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection
G J Mertz, C W Critchlow, J Benedetti, et al.
Page
of 80
Search research articles
Search
Showing results (371-380 of 792) with videos related to
Sort By:
Page
of 80
The Journal of Infectious Diseases
|
November 1, 1995
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 Team
R H Haubrich, C Flexner, M M Lederman, et al.
The New England Journal of Medicine
|
August 27, 1992
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group
J O Kahn, S W Lagakos, D D Richman, et al.
Antiviral Therapy
|
February 6, 2004
Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance
Joel E Gallant, Peter Z Gerondelis, Mark A Wainberg, et al.
The Journal of Biological Chemistry
|
August 5, 1993
Amino acid substitutions in HIV-1 reverse transcriptase with corresponding residues from HIV-2. Effect on kinetic constants and inhibition by non-nucleoside analogs
A Bacolla, C K Shih, J M Rose, et al.
Medical Care
|
August 11, 1991
A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection
A W Wu, H R Rubin, W C Mathews, et al.
Nature
|
September 6, 1990
Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies
J M Zarling, P A Moran, O Haffar, et al.
Journal of Clinical Microbiology
|
August 1, 1987
Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection
R S Smith, R B Naso, J Rosen, et al.
Plos Pathogens
|
November 30, 2016
Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model
Cory H White, Bastiaan Moesker, Nadejda Beliakova-Bethell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials
J F Seligmann, D Fisher, C G Smith, et al.
JAMA
|
September 7, 1984
Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection
G J Mertz, C W Critchlow, J Benedetti, et al.
Page
of 80